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Abstract
Background: Congenital malaria has been considered a rare event; however, recent reports have shown
frequencies ranging from 3% to 54.2% among newborns of mothers who had suffered malaria during pregnancy.
There are only a few references concerning the epidemiological impact of this entity in Latin-America and
Colombia.
Objective: The aim of the study was to measure the prevalence of congenital malaria in an endemic Colombian
region and to determine some of its characteristics.
Methods: A prospective, descriptive study was carried out in the mothers who suffered malaria during pregnancy
and their newborns. Neonates were clinically evaluated at birth and screened for Plasmodium spp. infection by
thick smear from the umbilical cord and peripheral blood, and followed-up weekly during the first 21 days of
postnatal life through clinical examinations and thick smears.
Results: 116 newborns were included in the study and 80 umbilical cord samples were obtained. Five cases of
congenital infection were identified (four caused by P. vivax and one by P. falciparum), two in umbilical cord blood
and three in newborn peripheral blood. One case was diagnosed at birth and the others during follow-up.
Prevalence of congenital infection was 4.3%. One of the infected newborns was severely ill, while the others were
asymptomatic and apparently healthy. The mothers of the newborns with congenital malaria had been diagnosed
with malaria in the last trimester of pregnancy or during delivery, and also presented placental infection.
Conclusions: Congenital malaria may be a frequent event in newborns of mothers who have suffered malaria
during pregnancy in Colombia. An association was found between congenital malaria and the diagnosis of malaria
in the mother during the last trimester of pregnancy or during delivery, and the presence of placental infection.
Background
Most neonatal and perinatal deaths are preventable.
According to The State of the World’s Children report,
published in 2009, 3.7 million children die annually during
the first 28 days of postnatal life, 75% during the first week
and 36% due to severe infection [1]. Malaria continues to
be one of the most important public health problems
worldwide, and is responsible for 8% of the mortality
among children below the age of five [1]. Plasmodium spp.
is usually transmitted by Anopheles spp. mosquitoes, but
can also be transmitted from mother to child causing con-
genital malaria (CM) [2]. Maternal and placental infections
caused by Plasmodium spp. are frequent entities in malaria
endemic regions and have been extensively studied in
Africa, Asia and Oceania; in contrast, there is little
information regarding CM. The first studies by Covell and
Bruce-Chwatt in the midst of the 20
th century reported an
incidence of CM between 0.18% and 0.3% in newborns
from mothers suffering from malaria during pregnancy in
hyper-endemic regions [3,4], and only 300 sporadic cases
were reported worldwide in the literature during the next
half century; therefore, CM has been considered a rare
event [5]. However, since 1985 there have been reports of
a CM incidence ranging from 4.9% to 54.2% in regions of
Africa with stable malaria transmission, where it is more
likely that the pregnant women have acquired immunity
to prevent mother-to-child transmission [6-11]. The few
reports in Latin America include some cases from Brazil,
Mexico and Honduras [12-15], and a case-control study
that reported a congenital infection incidence of 3.3% [16].
In Colombia, 12 cases were reported before 1986 [17] and
there is a recent report on five cases of severe neonatal
malaria caused by Plasmodium vivax,o n eo ft h e mw i t h
congenital infection based on epidemiological criteria [18].
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magnitude of CM in malaria endemic regions in Colom-
bia, this study was designed to evaluate the prevalence of
CM in a high-endemic region in Colombia and to describe
its clinical and epidemiological characteristics.
Methods
Study location
This investigation was carried out in the Caribbean
region of Urabá (Department of Antioquia, Colombia).
This region is close to the Panama border, with tropical
rainforest ecosystems and a population of 509,409 people,
most of them African descendants (51.5%) and under 25
years of age (59.0%). Banana growing and cattle farming
are the main economic activities in this region [19]. The
study was conducted in the municipalities of Apartadó
(7° 52’ 40’’ N; 76° 37’ 44’’ W), Carepa (7° 45’ 12’’N; 76° 39’
21’’W), Turbo (8° 05’ 42’’N; 76° 44’ 23’’W) and Necoclí
(8° 25’ 39’’N; 76° 46’ 58’’W). The annual incidence of
malaria in the region was higher than 40 cases per 1,000
inhabitants during 1998-2007, with unstable transmis-
s i o n ,a n dw h e r em o r et h a n7 5 %o fr e p o r t e dc a s e sw e r e
caused by P. vivax [20]. An incidence of 4.1 cases of
gestational malaria for each 1,000 live births has also
been reported in this region [21].
Study design and study population
This was a prospective, descriptive study that was part of
a larger epidemiological study on gestational malaria that
included 2,117 pregnant women and was carried out
from 2005-2007 by the Malaria Group of the Universidad
de Antioquia in Colombia. Pregnant women were
screened for Plasmodium spp. infection by thick smear at
each prenatal visit and during delivery, and/or when they
consulted due to a febrile syndrome. At birth, newborns
from mothers who had a diagnosis of malaria in preg-
nancy (MIP) were clinically assessed and thick smears
from peripheral blood and umbilical cord were analysed
for the presence of the parasite. Weekly clinical and para-
sitological follow-up was carried out for 21 days in new-
borns, according to the criteria proposed by Henrys for
CM in unstable transmission areas [22], such as this
Latin-American region. The units of analysis were the
newborns or the umbilical cords of mothers who had suf-
fered MIP.
Sample size
The appropriate sample size was calculated [23] based on
an annual average of 11,000 births [24], with a 10% esti-
mated frequency of MIP (n = 1,650 newborns from
mothers with MIP), and a 7% expected frequency of CM.
The calculated sample size was 95 units of analysis, and
we added 20% more to make up for possible losses dur-
ing the follow-up period. A total of 116 newborns were
finally selected according to the following inclusion
criteria: 1) child of a pregnant woman who had been
diagnosed with Plasmodium infection during prenatal
control and/or during delivery, 2) newborn residing in
the municipalities where the study was carried out, and
3) informed consent from the mother or guardian for the
newborn’s participation in the study.
Definitions
Congenital malaria: 1) newborn of a MIP mother with an
infection caused by the same Plasmodium species at birth
or during the 21-days follow-up period or 2) Plasmodium
spp. infection of the umbilical cord [18].
Adolescent: under 20 years of age [25].
Low birth weight (LBW): less than 2,500 g [26].
Preterm birth (PB): birth before 37 weeks of gestation
[26].
S m a l lf o rg e s t a t i o n a la g e :below the 10
th percentile of
weight for gestational age, according to Lubchenco
curves [26].
Gestational age: determined by ultrasound or the first
day of the mother’s last menstrual period.
Thick smears
Peripheral blood thick smear
capillary puncture was performed and the first drop of
blood was discarded; the following drops were used for
diagnosis [27]. Thick smears were stained with Field stain
and read under a light microscope at 100× magnification.
Parasitaemia was estimated against 200 leukocytes (8,000
leukocytes/μL, standard value) and was expressed as para-
sites/μL. P. falciparum parasitaemia was calculated count-
ing ring forms, while P. vivax parasitaemia was calculated
counting all asexual forms. A sample was considered nega-
tive if after the examination of 200 microscopic fields, no
parasites were observed or when only P. falciparum game-
tocytes were observed [28].
Umbilical cord thick smear
1 mL of blood was extracted from the umbilical vein
during delivery [23]. Two thick smears were made and
analysed using the same technique previously described
[28].
Placental blood thick smear
placentas were cleaned with 50 mL of 0.9% saline solu-
tion. A 1-cm
3 incision was made in a cotyledon close to
the umbilical cord, from where placental blood samples
were collected [29].
Data collection
Newborn data from birth, physical exam and anthropo-
metric measurements were registered in a standardized
form (Latin-American Centre for Perinatology) [30].
Registered variables were gender, birth weight, height,
cephalic perimeter, and the APGAR score at one and
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uated by a physician on a weekly basis, and thick blood
smears were made from peripheral blood.
Statistical analysis
Statistical analyses were made with EpiInfo software, ver-
sion 6.04 (Center for Disease Control and Prevention,
USA; World Health Organization, Geneva, Switzerland). A
descriptive analysis was made to summarise and present
the information. Median and interquartile range (IQR) or
mean and confidence interval were calculated for continu-
ous variables (according to normal distribution of data),
and absolute frequency and percentages were used for
categorical variables. Mann Whitney’s test and chi-squared
test were used to compare maternal and neonatal charac-
teristics between the newborn groups with and without
CM. A significance level of 5% was chosen.
Ethical considerations
The project was approved by the Ethics Committee of the
Faculty of Medicine, Universidad de Antioquia. The
Colombian Ministry of Health research standards (resolu-
tion 008430/1993), the WHO ethical standards for
research on human beings and the 2002 Helsinki declara-
tion were taken into account. Informed consent was
obtained from all the mothers of the newborns or from
their legal guardians.
Results
Findings in the mothers and newborns
From a total of 220 pregnant women who were diagnosed
with MIP during prenatal control, only 157 gave birth in a
health facility and were accessible; 116 of them were
selected to be included in the study after fulfilling the cri-
teria. The general characteristics of the mothers and new-
borns included (n = 116) and not included (n = 41) in the
study are shown in Table 1. The only statistically signifi-
cant difference between the mothers included and not
included in the study was found in the median of years of
residence in endemic areas (p = 0.024), the other charac-
teristics were similar.
37.9% of the mothers included in the study were ado-
lescents and 6.4% were over 35 years of age; 21.8% were
primigravida, 19.5% reported 3 or more previous preg-
nancies, and 69.8% had been living in malaria risk areas
for 10 years or longer. 91.4% of the pregnant women
were attending a prenatal care program with a median of
4 visits, 34.5% reported having at least one episode of
malaria in the previous year, and 12.7% had PB; 9.1% of
the newborns had LBW and 18.2% were small for gesta-
tional age.
One hundred and sixty-eight episodes of malaria (138
caused by P. vivax and 30 by P. falciparum)w e r ed i a g -
nosed among the 116 mothers (average, 1.4 episodes per
mother). The median for the gestational age at the time of
diagnosis of the first malaria episode was 30.1 weeks (IQR:
22.2-35.8). Twenty-seven episodes of malaria were diag-
nosed in the mothers during delivery, 21 caused by
P. vivax and six by P. falciparum; the median parasitaemia
was 2,400 parasites/μL (IQR: 400-5,560).
Findings in the placenta
Ninety-four placental blood samples were obtained from
the 116 mothers; 17 (18%) had Plasmodium infection
(14 P. vivax and three P. falciparum)w i t ham e d i a n
parasitaemia of 200 parasites/μL (IQR: 80-920). Two
mothers who were reported as negative for Plasmodium
infection in peripheral blood samples during the prena-
tal control and delivery, had parasites in the placentas
(one P. vivax and one P. falciparum).
Congenital malaria prevalence
Of the 80 blood samples collected from the umbilical
cords at birth, two (2.5%) were positive for P. vivax.T h e
116 newborns were followed-up for 20.5 ± 1.1 days with
an average of 2.8 ± 1 postnatal controls per neonate. Dur-
ing follow-up, three (2.6%) neonates were diagnosed with
Plasmodium spp. infection; two by P. vivax (one at birth
and one on day 14), and one by P. falciparum (on day 8).
CM was diagnosed in five cases, for a prevalence of 4.3%,
three diagnosed in the 116 newborns and two in the 80
umbilical cords. None of these results were positive in
both units of analysis simultaneously.
Characteristics of mothers and newborns with and
without CM
There were no significant differences in the characteristics
of mothers of newborns with and without CM (p > 0.05)
(Table 2). The median age of mothers with newborns with
CM was 23 years (IQR: 21.5-31), had a median of 1.0 for
previous pregnancies (IQR: 1.0-3.5), and had attended at
least four prenatal controls. The median episodes of
malaria during the current pregnancy was 1.0 (IQR: 1.0-
1.5), and the median gestational age at the time of mater-
nal malaria diagnosis was 30 weeks (IQR: 25.6-39.4). The
median gestational age of the mothers of CM cases was
37.7 weeks (IQR: 37.3-40.3).
There were no significant differences in the anthropo-
metric characteristics and neonatal adaptability among
neonates with and without CM (Table 2). Medians of
weight, length and cephalic perimeter at birth of CM cases
were 3,000 g (IQR: 2800-3400), 48 cm (IQR: 44-49.5) and
34 cm (IQR: 31.5-34), respectively; all these measurements
were above the 10
th percentile according to the Lubchenco
curves.
The mother of the congenital case caused by P. falci-
parum presented clinical and laboratory signs compatible
with severe malaria (parasite count of 106,640 ring forms/
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required hospitalization in a high complexity health insti-
tution in the immediate postpartum period. The mothers
of the other CM cases, caused by P. vivax, were classified
as having acute non-complicated malaria; three were diag-
nosed at the time of delivery and had concomitant placen-
tal infection, and one was diagnosed in the third trimester
of pregnancy during the prenatal control (Table 3). All
mothers and infected newborns received anti-malarial
treatment according to the national protocols [31].
Newborns with P. vivax infection in the umbilical cord
(Table 3, case 1 and case 4) did not show infection in
peripheral blood during follow-up or manifested clinical
signs of active infection or severe disease; thus, no anti-
Table 1 General characteristics of the mothers and newborns included and not included in the study
Variable Cases included in the study Cases not included in the study Mann-Whitney
p value
nQ 2
(Q1 - Q3)
nQ 2
(Q1 - Q3)
Maternal age 115 21
(18 - 27)
40 22
(18 - 28)
0,845
Maternal haemoglobin after week 20 (g/dL) 80 11.5
(10.1-2.0)
21 11.6
(10.7 - 11.6)
0,855
Years of residence in malaria area 114 18
(10 - 23)
41 15
(5 - 20)
0,024
Previous pregnancies 116 2
(1-3)
41 1
(1-3)
0.91
Episodes of malaria in the previous year 78 0
(0 - 1)
33 0
(0 - 1)
0,347
Gestational age at birth 109 38.4
(37.8 - 39.7)
38 39
(37.7 - 40)
0,055
Neonatal weight 115 2875
(2500 - 3425)
39 3005
(2800 - 3400)
0,280
Neonatal length 116 48
(47 - 50)
40 49
(47 - 50)
0,697
APGAR at 1 minute 112 8
(7 - 9)
40 8
(8 - 9)
0,616
Episodes of malaria during current pregnancy 116 1
(1 - 1)
41 1
(1 - 2)
0,166
Q2: median Q1-Q3: quartil 1-quartil 3.
Table 2 Maternal and neonatal characteristics of congenital and non-congenital malaria groups
Variables Congenital malaria (n =
5)
Non congenital malaria (n =
111)
p
value
Maternal characteristics
Maternal age (years), median (Q1-Q3) 23 (21.5-31) 22 (18-28) 0.550
Previous pregnancies, median (Q1-Q3) 1 (1-3.5) 1 (1-3) 0.676
Years of residence in endemic areas, median (Q1-Q3) 22 (10.5-28) 15 (5-19.5) 0.135
Episodes of malaria in the previous year, median (Q1-Q3) 0 (0-0) 0 (0-1) 0.340
Episodes of malaria during current pregnancy, median (Q1-Q3) 1 (1-1.5) 1(1-2) 0,476
Gestational age at the time of malaria diagnosis (weeks), median (Q1-
Q3)
30 (25.6-39-4) 30.3 (21.5-35.4) 0.662
Arterial hypertensive disorders during pregnancy, (%) 25 6.9 0.275*
Urinary tract infections, (%) 0 26.3 0.570*
Preterm birth, (%) 20 11.3 0.470*
Neonatal characteristics
Weight (grams), median (Q1-Q3) 3000 (2800-3400) 3200 (2200-3475) 0.633
Length (cm), median (Q1-Q3) 48 (44-49.5) 49 (47.5-50) 0.406
Cephalic perimeter (cm), median (Q1-Q3) 34 (31.5-34) 34 (33-34) 0.238
APGAR at 1 minute, median (Q1-Q3) 8 (5.5-9) 8 (8-9) 0.477
*Fisher’s exact test, Q1-Q3: quartil 1-quartil 3.
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CM case was severely ill since birth due to prematurity
and to hyaline membrane disease (Table 3, case 5). Dur-
ing hospitalization in a neonatal intensive care unit, the
newborn was diagnosed with early neonatal sepsis by
Escherichia coli. The thick smear was negative at birth,
but serial thick smears started on day 6 revealed P. falci-
parum infection on day 8 (120 rings/μL).
Discussion
CM is one of the least known and studied adverse events
of MIP [2]. The present study is the first epidemiological
report about CM in Colombia and could be considered as
being one of the first for regions where P. vivax malaria is
the most frequent specie. This study found a prevalence of
CM of 4.3% among newborns from mothers with MIP in
the Urabá region. Such frequency was similar to that
found in Nigeria by Falade et al, who identified a 5.1%
parasitaemia in samples from newborns whose mothers
had suffered from MIP [11], and to the prevalence of 3.3%
(1/30) found by Fernández et al in Honduras in 2001 [16],
but greater than that reported by Alves et al in Brazil, who
found just one case of CM in 2,781 cases of malaria
between 1980 and 1994 in the Campinas region [15]. 80%
(four out of five) of CM cases in this study were caused by
P. vivax, the Plasmodium responsible for most of the
malaria cases in the Americas [32].
The umbilical cord and newborns were the units of
analysis for obtaining such prevalence, and the first 21
days of life were defined as the time limit for obtaining
samples. Although in P. falciparum hyper-endemic
regions the first seven days of life are the limit to define
an infection as congenital, we chose a time limit that
has been proposed for areas of low endemicity and
unstable transmission, which is an accepted limit for
infections caused by non P. falciparum species [22].
One of cases was identified at postnatal day14, within
the time limit, however it is not possible to guarantee
that it was not caused by vector transmission of the
parasite because we had no information on the control
measures used to protect this neonate against malaria;
the question remains on whether it was a postnatal
infection, however if we consider the unstable and low
malaria transmission rates of the study location, is not
likely that this occurred. The CM case by P. falciparum
was diagnosed at postnatal day 8, however this newborn
was referred after birth to the Neonatal Care Unit
located in a non-endemic area, so we consider it was
indeed a case of CM.
Positive umbilical cords and neonatal peripheral blood
samples from units of analysis were included for calculat-
ing the prevalence, and all complete or partial units
formed the denominator. It became evident in this study
that obtaining samples from these two sites was essential
for diagnosing CM and determining the magnitude of
this disease. If the units of analysis were divided accord-
i n gt os a m p l es i t e ,ap r e v a l e n c eo f2 . 5 %( 2 / 8 0 )a n do f
2.6% (3/116) would have been obtained for malaria posi-
tive samples from the umbilical cord and neonatal per-
ipheral blood, respectively.
The prevalence of CM reported here was obtained using
thick smear as the diagnostic test; however, a greater pre-
valence might have been found if more sensitive techni-
ques, such as PCR, had been used. Kamwendo et al and,
recently, Mwangoka et al have found in P. falciparum
endemic regions that when using thick smears to diagnose
Table 3 Malaria and thick smear findings in CM cases
Case 1 Case 2 Case 3 Case 4 Case 5
Malaria findings
Episodes of maternal malaria 1 Pv 1 Pv
1 Pf
1 Pv 1 Pv 1 Pf
Gestational age at malaria diagnosis (weeks +
days)
37 + 2 Pf:2 4+2
Pv:4 0+ 2
27 + 6 40 + 4 30
Type of malaria syndrome in mothers acute
uncomplicated
malaria
acute
uncomplicated
malaria
acute
uncomplicated
malaria
acute
uncomplicated
malaria
severe
malaria
Clinical status of neonates at the time of
congenital malaria diagnosis
afebrile afebril afecrile afebrile severely ill
Thick smear findings
Maternal blood during delivery Pv (nd) Pv (560) Neg. Pv (120) Pf
(106640)
Placental blood Pv (920) Pv (440) Neg. Pv (80) Neg.
Umbilical cord blood Pv 1860) Neg. Neg. Pv (80) Neg.
Neonatal blood Neg. Pv (40) day 1 Pv (160) day 14 Neg. Pf (120)
day 8
Pv: Plasmodium vivax, Pf: Plasmodium falciparum
( ) parasite/μL.
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range from 0.4% to 6.0%, and when PCR is used the fre-
quencies increase to 20% to 61% for samples taken from
the same site [33,34].
Low parity, fever during the last trimester of gestation,
maternal malaria at birth, placental infection by Plasmo-
dium spp. and low socioeconomic level have all been
associated with greater CM frequency [11,35,36]. Age of
pregnant mother and maternal infection by HIV have
been associated with greater Plasmodium trans-placental
transmission risk, with a higher infection frequency and
placental damage [37-40]. Falade et al in 2002, high-
lighted the strong relationship between maternal parasi-
taemia at birth and positive placental samples with
congenital infection [11].
The study identified four cases of CM, three by P. vivax
and one by P. falciparum, where the mothers had malaria
during delivery; placental infection was also found in the
three CM cases by P. vivax. The other mother had
P. vivax malaria 10 weeks before giving birth. A previous
report by our group on neonatal malaria (where vertical
P. vivax transmission was suspected), showed that two of
the four positive mothers were in their first or second
gestation [18]; the present study found that three (60%)
of the five mothers of the CM cases were secundiparous.
In contrast to other reports [18,41], the mothers of the
CM cases in the present study were older than 20 years
of age.
LBW has been associated with infection by P. falci-
parum during pregnancy and at birth, which is explained
by a combination of intrauterine growth restriction and
PB [42] in both high and low malaria transmission regions,
accompanied by almost a four-fold increased risk when
there has been placental infection [41]. In this study, only
the newborn infected by P. falciparum weighed less than
2,500 grams and was born at week 30 of gestation. Such
PB could have been due to the mother presenting P. falci-
parum infection at birth. Infection by this species has been
associated with a greater risk of PB due to the magnitude
of the induced inflammatory response. Many reports have
associated LBW with MIP caused by P. falciparum [41],
but only a few have shown the effect of the infection by
P. vivax on birth weight. Nosten et al reported an
increased risk of LBW associated with P. vivax infection
[43]. The absence of LBW in CM cases of mothers with
MIP by this specie was notable in this report; this could be
explained because the infection occurred at the end of the
gestation and the gestations went to full term. Anthropo-
metric measurements in all newborns, including the pre-
mature case, were appropriate for the gestational age.
In low endemic and unstable transmission areas the
acquisition of immunity against Plasmodium spp. is diffi-
cult and incomplete, so there is little passage of antibodies
through the placenta [41]. In this scenario, the clinical
manifestations of a CM case are usually fever accompanied
by irritability, anorexia, hepatosplenomegaly, haemolytic
anaemia and ichtericia [14,18,44]. In contrast, in high
endemic and stable transmission regions where it is con-
sidered that the opposite is true, signs and symptoms of
active infection are infrequent [45,46].
This study location had unstable transmission of
malaria, which has thus hampered the induction of effec-
tive immunity against the parasite. In contrast to a pre-
vious report on cases of neonatal malaria by P. vivax in
the same region, in which the newborns presented severe
d i s e a s e[ 1 8 ] ,i nt h ep r e s e n ts t u d yt h eC Mc a s e sb yt h i s
specie were asymptomatic. This difference could have
been due to the infections being identified during the
pre-clinical phase as a consequence of active search, and
to a timely treatment.
The newborn with CM by P. falciparum presented a
very serious disease requiring treatment in a neonatal
intensive care unit outside the endemic zone. Other condi-
tions including sepsis by Escherichia coli, hyaline mem-
brane disease and PB converged in this patient and can
explain the extreme severity of the clinical picture.
Research in severe malaria has shown that some cases of
extreme clinical severity in both children and adults can
be explained by co-infection with bacterial agents [47]
which, even in the case of Gram negative bacteraemia,
have been reported as increasing the risk of death from
malaria [48,49].
Conclusions
1) CM is a frequent event in newborns of mothers
who have had malaria during pregnancy in a coastal
region of Colombia;
2) The main maternal characteristics in these cases of
CM were having malaria during the last trimester or
during delivery, and placental infection.
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